2017 International Meeting on the Molecular Biology of Hepatitis B Viruses

2017年乙型肝炎病毒分子生物学国际会议

基本信息

批准号：
9330983
负责人：
Timothy M Block
金额：
$ 0.63万
依托单位：
HEPATITIS B FOUNDATION
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-08-15 至 2018-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9330983
关键词：
Address Animal Model Anniversary Antiviral Agents Antiviral Therapy Basic Science Biochemistry Biology Biomedical Research Cellular biology Cessation of life Chronic Circular DNA Cirrhosis Communities Development Discipline Disease District of Columbia Financial Support Foundations Fund Raising Funding Future Gene Expression Goals Grant Hepatitis B Hepatitis Delta Virus Home environment Immunology Individual Infection International Joints Knowledge Light Liver Failure Liver diseases Malignant Neoplasms Mission Modality Molecular Biology National Cancer Institute National Institute of Allergy and Infectious Disease National Institute of Diabetes and Digestive and Kidney Diseases National Institute of General Medical Sciences Oral Pathogenesis Population Postdoctoral Fellow Preventive vaccine Primary carcinoma of the liver cells Public Health RNA Editing Regulatory Element Research Research Personnel Schedule Scientist Senior Scientist Structure Supervision Therapeutic Time Travel Underrepresented Minority United States National Institutes of Health Universities Vaccines Viral Virus Virus Diseases Virus Shedding cost gene therapy graduate student interest lecturer meetings minority investigator pathogen posters protein expression symposium vector virology virus pathogenesis

项目摘要

2017 International HBV Meeting Project Summary/Abstract In this proposal, we request for funding to support the travel expenses for young scientists to attend and participate in the 2017 International Meeting on the Molecular Biology of Hepatitis B Viruses, scheduled for September 3-7, 2017 at the Omni Shoreham Conference Center and Hotel, Washington DC. This meeting is the only forum that gathers the international community of researchers that focus on the hepatitis B virus (HBV) and the closely associated hepatitis delta virus (HDV). Approximately 25% of the world's population has been infected by HBV. Unfortunately, despite the availability of prophylactic vaccines, many new infections occur worldwide, mostly because of underutilization of the vaccine due to cost and other issues. Moreover, for the approximately 350 million people already chronically infected with HBV (approximately 15 million of whom are co-infected with HDV), the vaccine is of no therapeutic value. As a result, between 0.5 and 1 million people die of HBV/HDV every year worldwide. It is therefore imperative that basic research on HBV continues, and the latest progress in the field is discussed and disseminated in a timely manner. The annual HBV meeting provides the forum for scientific exchanges and the dissemination of latest research information. The 2017 meeting will uphold and enhance the traditional format. It will consist of 8 oral scientific sessions and 2 poster sessions as well as less structured “networking” time. The scientific interactions will be facilitated by 3-4 keynote addresses. As in the past, great effort has been made to minimize the cost of the meeting. Furthermore, the Hepatitis B Foundation has made a strong commitment to support this meeting since 2005, in terms of providing a permanent home for organizing the meeting and making its staff available for supervising the meeting and publicizing it, especially to universities with large numbers of underrepresented minorities. In order to allow the participation of junior and minority investigators, support from the NIH to help defray the meeting costs is requested. It is expected that 300-400 attendees will register for the 2017 HBV meeting, which will mark the 33rd anniversary of the HBV meeting.

2017年国际乙型肝炎会议项目总结/摘要在这个提案中，我们请求资金来支持年轻科学家参加和参加2017年乙型肝炎病毒分子生物学国际会议 2017 年 9 月 3 日至 7 日在华盛顿特区 Omni Shoreham 会议中心及酒店举行。唯一聚集了专注于乙型肝炎病毒 (HBV) 的国际研究人员的论坛以及与之密切相关的丁型肝炎病毒 (HDV)，世界上大约 25% 的人口已感染该病毒。不幸的是，尽管有预防性疫苗，但还是出现了许多新的感染。在世界范围内，主要是由于成本和其他问题导致疫苗利用不足。大约 3.5 亿人已经慢性感染 HBV（其中大约 1500 万人是乙肝病毒感染者）与 HDV 合并感染），疫苗没有治疗价值，因此导致 0.5 至 100 万人死亡。每年全世界都有 HBV/HDV 发生，因此继续进行 HBV 基础研究势在必行。乙肝年会及时讨论和传播该领域的最新进展。提供科学交流和传播最新研究信息的论坛。会议将秉承并加强传统形式，由8场口头科学会议和2张海报组成。 3-4 次会议以及结构性较低的“社交”时间将促进科学互动。与过去一样，我们付出了巨大的努力来尽量减少会议的成本。此外，自 2005 年以来，乙型肝炎基金会坚定承诺支持本次会议，为组织会议提供永久住所并让其工作人员进行监督的条款会议并对其进行宣传，特别是向拥有大量代表性不足的少数族裔的大学。为了允许初级和少数族裔研究人员参与，NIH 提供支持以帮助支付预计将有 300-400 名与会者报名参加 2017 年 HBV 会议。将纪念 HBV 会议召开 33 周年。